Acting Commissioner Von Eschenbach Made Permanent In Time For New Year
This article was originally published in The Rose Sheet
Executive Summary
Andrew von Eschenbach can delete "acting" from his office nameplate; the Senate confirmed him as FDA commissioner Dec. 7 by a comfortable 80-11 margin, ending months of "holds" on the vote and opposition to his nomination from both sides of the aisle
You may also be interested in...
FDA Head Von Eschenbach Resigning In January; Industry Awaits Successor
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, closing out a bumpy tenure marked by some notable successes
FDA Head Von Eschenbach Resigning In January; Industry Awaits Successor
FDA Commissioner Andrew von Eschenbach will return to Texas upon resigning his post Jan. 20, closing out a bumpy tenure marked by some notable successes
New staff chief for von E
Three months after moving to FDA from the American Pharmacists Association (APA) Susan Winckler is named acting chief of staff for FDA Commissioner Andrew von Eschenbach. Winckler, an attorney, joined FDA in September 2006 as policy communications director in the commissioner's Office of Policy & Planning, where she was the point person for constituent communications and policy development relevant to FDA advisory committees. Starting in January 2007, Winckler will coordinate staff activities and be the principal liaison to HHS. The Senate confirmed von Eschenbach as FDA commissioner Dec. 7 (1"The Rose Sheet" Dec. 11, 2006, p. 10)...